Compositions and Uses Thereof
AssigneePurposeful IKE
InventorsGeorgios Drakakis, Charalampos Chomenidis, Georgia Tsiliki
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions for use in the treatment, management or amelioration of FMR1 mediated autism and Fragile X Syndrome (FXS), wherein the composition comprises one or more triptans or derivatives thereof. The invention also relates to one or more triptans or derivatives thereof and one or more ergot alkaloids, derivatives or mimetics thereof for use as medicaments for treating a range of autistic diseases and diseases having an autistic component.
Claims30
A composition for use in the treatment, management or amelioration of FMR1 mediated autism, wherein the composition comprises one or more triptans or derivatives thereof.
A composition for use in the treatment, management or amelioration of Fragile X Syndrome (FXS), wherein the composition comprises one or more triptans or derivatives thereof.
A composition comprising the combination of one or more triptans or derivatives thereof and one or more ergot alkaloids, derivatives or mimetics thereof.
A combination of an SSRI and a composition comprising one or more triptans or derivatives thereof, for use in the treatment, management or amelioration of an autism disease or disease where autism is a known component, for example FMR1 mediated autism.
Dependencies are inferred from the claim text.